James Paul Abernathy
Known title: DirectorCIK: 0001261687
James Paul Abernathy's purchase track record
James Paul Abernathy has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/23/2023 | NHC | $125K | +2.6% | +19.7% | +9.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| NHC | ▲ Buy | Option Exercise | 3,140 | $175K | 3/9/2026 | View on chart |
| NHC | ▲ Buy | Option Exercise | 7,500 | $524K | 1/15/2026 | View on chart |
| NHC | ▼ Sell | Tax Withholding | 3,732 | $519K | 1/15/2026 | View on chart |
| NHC | ▲ Buy | Option Exercise | 4,010 | $287K | 8/13/2025 | View on chart |
| NHC | ▼ Sell | Tax Withholding | 2,639 | $287K | 8/13/2025 | View on chart |
| NHC | ▲ Buy | Option Exercise | 1,745 | $125K | 2/20/2025 | View on chart |
| NHC | ▼ Sell | Open Market | 1,605 | $204K | 8/14/2024 | View on chart |
| NHC | ▲ Buy | Option Exercise | 1,745 | $125K | 2/16/2024 | View on chart |
| NHC | ▲ Buy | Option Exercise | 5,895 | $459K | 1/4/2024 | View on chart |
| NHC | ▼ Sell | Tax Withholding | 4,912 | $459K | 1/4/2024 | View on chart |
| NHC | ▲ Buy | Option Exercise | 7,500 | $485K | 1/4/2024 | View on chart |
| NHC | ▼ Sell | Tax Withholding | 5,185 | $485K | 1/4/2024 | View on chart |
| NHC | ▼ Sell | Open Market | 1,550 | $106K | 8/24/2023 | View on chart |
| NHC | ▲ Buy | Open Market | 2,176 | $125K | 2/23/2023 | View on chart |
| NHC | ▲ Buy | Option Exercise | 2,020 | $125K | 5/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
NHC highlighted in SeekingAlpha dividend champion roundup
SeekingAlpha’s weekly dividend review listed National HealthCare Corp as a dividend champion, contender and challenger. The mention underscores the company’s 3.07% yield and its position among dividend‑focused investors. With the stock trading near the middle of its 52‑week range, the coverage adds visibility to its dividend profile.
NHC highlighted in SeekingAlpha dividend champion roundup. SeekingAlpha’s weekly dividend review listed National HealthCare Corp as a dividend champion, contender and challenger. The mention underscores the company’s 3.07% yield and its position among dividend‑focused investors. With the stock trading near the middle of its 52‑week range, the coverage adds visibility to its dividend profile.